CR8406A - Forma de administracion del naproxeno sodico - Google Patents
Forma de administracion del naproxeno sodicoInfo
- Publication number
- CR8406A CR8406A CR8406A CR8406A CR8406A CR 8406 A CR8406 A CR 8406A CR 8406 A CR8406 A CR 8406A CR 8406 A CR8406 A CR 8406A CR 8406 A CR8406 A CR 8406A
- Authority
- CR
- Costa Rica
- Prior art keywords
- weight
- sodium naproxen
- tablet core
- administration
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un comprimido no efervescente de naproxeno sodico, que consta de un nucleo de comprimido y si se desea de un revestimiento de azucar o de una pelicula, donde el nucleo del comprimido, respecto al peso del nucleo del comprimido, se compone de un 30 hasta de un 99% en peso de naproxeno sodico y de un 70 hasta de un 1% en peso de componente de materia auxiliar, que incluye como minimo una sustancia auxiliar basica, posee una dureza suficiente, es comparativamente pequeno y conduce a un aumento del nivel de sangre especialmente rapido y con ello a una accion analgesica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH18482003 | 2003-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8406A true CR8406A (es) | 2008-04-25 |
Family
ID=34529359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8406A CR8406A (es) | 2003-10-30 | 2006-05-15 | Forma de administracion del naproxeno sodico |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070134317A1 (es) |
| EP (1) | EP1684728B1 (es) |
| JP (1) | JP2007509862A (es) |
| AR (1) | AR046213A1 (es) |
| AT (1) | ATE442840T1 (es) |
| BR (1) | BRPI0415624A (es) |
| CA (1) | CA2543709A1 (es) |
| CR (1) | CR8406A (es) |
| DE (1) | DE602004023220D1 (es) |
| EC (1) | ECSP066587A (es) |
| ES (1) | ES2333332T3 (es) |
| PA (1) | PA8616101A1 (es) |
| PE (1) | PE20050445A1 (es) |
| UY (1) | UY28583A1 (es) |
| WO (1) | WO2005041938A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3216445A1 (en) * | 2004-05-28 | 2017-09-13 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
| US9205054B2 (en) | 2005-03-22 | 2015-12-08 | Losan Pharma Gmbh | Solubilized ibuprofen |
| EP3449928A1 (en) | 2005-11-28 | 2019-03-06 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
| GB201506755D0 (en) * | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
| US11278506B2 (en) * | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
| JP7163014B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 感冒薬 |
| JP7163015B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 経口固形組成物 |
| US11779541B2 (en) * | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| US5034416A (en) * | 1988-01-19 | 1991-07-23 | Smith Walton J | Carboxylic acid compositions |
| US5358717A (en) * | 1989-12-22 | 1994-10-25 | Syntex (U.S.A.) Inc. | Directly-compressible naproxen or naproxen sodium compositions |
| PT96229B (pt) * | 1989-12-22 | 1998-06-30 | Syntex Pharma Int | Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico |
| IT1272149B (it) * | 1993-03-26 | 1997-06-11 | Zambon Spa | Composizione farmeceutiche ad attivita' analgesica |
| GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
| US5948787A (en) * | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
| JPH10298072A (ja) * | 1997-04-17 | 1998-11-10 | Panacea Biotec Ltd | 非ステロイド性抗炎症剤の遷移金属錯体 |
| NZ333474A (en) * | 1998-01-02 | 1999-06-29 | Mcneil Ppc Inc | A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat |
| US6165506A (en) * | 1998-09-04 | 2000-12-26 | Elan Pharma International Ltd. | Solid dose form of nanoparticulate naproxen |
| US6383515B2 (en) * | 1999-05-28 | 2002-05-07 | Sawyer Maryjean | Solvent system for enhancing solubility |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| AU2002255190A1 (en) * | 2001-04-10 | 2002-10-28 | Fakhreddin Jamali | Composition for enhanced absorption of nsaids |
| WO2002083110A2 (en) * | 2001-04-10 | 2002-10-24 | Zagros Pharma, Inc. | Animal model for evaluating analgesics |
-
2004
- 2004-10-27 PE PE2004001035A patent/PE20050445A1/es not_active Application Discontinuation
- 2004-10-27 UY UY28583A patent/UY28583A1/es not_active Application Discontinuation
- 2004-10-28 PA PA20048616101A patent/PA8616101A1/es unknown
- 2004-10-28 AR ARP040103936A patent/AR046213A1/es not_active Application Discontinuation
- 2004-10-29 BR BRPI0415624-2A patent/BRPI0415624A/pt not_active IP Right Cessation
- 2004-10-29 US US10/577,197 patent/US20070134317A1/en not_active Abandoned
- 2004-10-29 AT AT04761983T patent/ATE442840T1/de not_active IP Right Cessation
- 2004-10-29 WO PCT/CH2004/000655 patent/WO2005041938A1/en active Application Filing
- 2004-10-29 CA CA000000008A patent/CA2543709A1/en not_active Abandoned
- 2004-10-29 EP EP04761983A patent/EP1684728B1/en active Active
- 2004-10-29 ES ES04761983T patent/ES2333332T3/es active Active
- 2004-10-29 JP JP2006537031A patent/JP2007509862A/ja active Pending
- 2004-10-29 DE DE602004023220T patent/DE602004023220D1/de active Active
-
2006
- 2006-05-15 CR CR8406A patent/CR8406A/es not_active Application Discontinuation
- 2006-05-29 EC EC2006006587A patent/ECSP066587A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0415624A (pt) | 2006-12-12 |
| ATE442840T1 (de) | 2009-10-15 |
| PE20050445A1 (es) | 2005-06-18 |
| US20070134317A1 (en) | 2007-06-14 |
| ES2333332T3 (es) | 2010-02-19 |
| UY28583A1 (es) | 2005-05-31 |
| CA2543709A1 (en) | 2005-05-12 |
| PA8616101A1 (es) | 2005-08-04 |
| ECSP066587A (es) | 2006-10-17 |
| EP1684728B1 (en) | 2009-09-16 |
| EP1684728A1 (en) | 2006-08-02 |
| JP2007509862A (ja) | 2007-04-19 |
| DE602004023220D1 (de) | 2009-10-29 |
| AR046213A1 (es) | 2005-11-30 |
| WO2005041938A1 (en) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8406A (es) | Forma de administracion del naproxeno sodico | |
| AR097045A2 (es) | Sistema terapéutico transdérmico | |
| CO6501159A2 (es) | Formulaciones farmaceuticas de liberación controlada de nitazoxanida | |
| UY26496A1 (es) | Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco | |
| UY33397A (es) | Forma sólida de un naftaleno carboxamida | |
| AR054060A1 (es) | Forma de dosificacion farmaceutica unitaria | |
| EA200700340A1 (ru) | Мультичастицы | |
| CL2008002407A1 (es) | Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04). | |
| GT200600046A (es) | Terapia de combinacion | |
| BRPI0513847A (pt) | formulação de comprimido de liberação extendida contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e uso do mesmo | |
| ECSP11010986A (es) | Combinación de una insulina y un agonista de glp-1 | |
| AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
| BRPI0413361B8 (pt) | comprimido seguro contra abuso termo-moldado por extrusão sem descoramento | |
| AR052190A1 (es) | Uso de clorantes de cianina para el diagnostico de enfermedades proliferativas | |
| AR062448A1 (es) | Conjugados de analogos de aziridinil-epotilona y composiciones farmaceuticas que comprenden los mismos | |
| NI200800175A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de abuso y adicción de sustancias. | |
| GT200600200A (es) | Composicion farmaceutica que contienen gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato | |
| UY29872A1 (es) | Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas | |
| AR041428A1 (es) | Forma de dosificacion de ibuprofeno sodico | |
| SG160415A1 (en) | Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative | |
| AR052165A1 (es) | Tratamiento de hepatitis c en la poblacion asiatica | |
| AR057932A1 (es) | Comprimido bicapa que comprende telmisartan y diuretico | |
| EA200400866A1 (ru) | Ламинированный инсектицидный диспенсер | |
| CL2007001748A1 (es) | Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras. | |
| CR9523A (es) | Tableta recubierta de azucar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |